Cargando…
Epigenetic inactivation of IRX4 is responsible for acceleration of cell growth in human pancreatic cancer
Epigenetic gene silencing by aberrant DNA methylation is one of the important mechanisms leading to loss of key cellular pathways in tumorigenesis. Methyl‐CpG‐targeted transcriptional activation (MeTA) reactivates hypermethylation‐mediated silenced genes in a different way from DNA‐demethylating age...
Autores principales: | Chakma, Kanchan, Gu, Zhaodi, Abudurexiti, Yakefujiang, Hata, Tatsuo, Motoi, Fuyuhiko, Unno, Michiaki, Horii, Akira, Fukushige, Shinichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734003/ https://www.ncbi.nlm.nih.gov/pubmed/32894817 http://dx.doi.org/10.1111/cas.14644 |
Ejemplares similares
-
TWIST1 is a prognostic factor for neoadjuvant chemotherapy for patients with resectable pancreatic cancer: a preliminary study
por: Fujiwara, Sho, et al.
Publicado: (2023) -
Expression of SNAIL in accompanying PanIN is a key prognostic indicator in pancreatic ductal adenocarcinomas
por: Fujiwara, Sho, et al.
Publicado: (2019) -
Neoadjuvant treatment for resectable pancreatic adenocarcinoma: What is the best protocol?
por: Motoi, Fuyuhiko, et al.
Publicado: (2020) -
Repeated Pancreatectomy for Metachronous Duodenal and Pancreatic Metastases of Renal Cell Carcinoma
por: Hata, Tatsuo, et al.
Publicado: (2013) -
Germline DNA damage repair gene mutations in pancreatic cancer patients with personal/family histories of pancreas/breast/ovarian/prostate cancer in a Japanese population
por: Hata, Tatsuo, et al.
Publicado: (2021)